Atlas Trials

Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma

Clinical trial NCT06653517 · RECRUITING

Trial details

NCT number
NCT06653517
Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
AmeloblastomaBRAF V600E Mutation Positive
Start date
2023-01-01
Primary completion
2026-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.